ArticleEuropean journal of haematology2025

Momelotinib Is Effective in Treatment for VEXAS Syndrome: Two Cases Within the AGMT Austrian Myeloid Registry.

Dominik Kiem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.